SGX to launch world's first DRAM futures

The Singapore Exchange (SGX) plans to offer the world's first futures contract based on dynamic random access memory (DRAM) chips by the first quarter of 2003, according to the exchange.

DRAM chips are used in a growing array of electronic products, and the industry made up a total of about $12 billion in revenues globally in 2001.

SGX embarked on the development of a DRAM futures contract after feedback from semiconductor chip manufacturers, users and other players in the electronics industry concerned about the need to manage risks following the high volatility in the price of DRAM chips over the last few years. At the same time, the exchange believes the futures contract will present unique opportunities for trading and arbitraging by players in the financial and futures industries.

"Introducing the world's first DRAM futures is a result of leveraging on our expertise and established infrastructure for financial derivatives instruments. It is in line with SGX's strategy to create cost-effective solutions for tomorrow's market, today," said Ang Swee Tian, president of the exchange.

The initiative is supported by the Infocomm Development Authority of Singapore (IDA) and the International Enterprise Singapore (IE Singapore).

SGX has also brought on board Semicon Exchange (SemiconX), a semiconductor trading platform provider, as an industry advisor to also assist the exchange in communicating with the semiconductor industry.

Subject to regulatory approval, the DRAM futures contract will be traded on the SGX derivatives market's electronic trading system (SGX ETS). The contract specifications, including the type of chip, will be finalised after further consultation with the industry. Meanwhile, the exchange expects the contract to be denominated in US dollars, with each contract sized at 10,000 pieces of DRAM with a value of approximately $70,000.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here